Align Technology, Inc.
General ticker "ALGN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $17.2B
Align Technology, Inc. does not follow the US Stock Market performance with the rate: -11.1%.
Estimated limits based on current volatility of 2.3%: low 211.54$, high 221.38$
Factors to consider:
- Company included in S&P500 list
- US accounted for 43.1% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [221.01$, 351.83$]
- 2024-12-30 to 2025-12-30 estimated range: [246.61$, 382.02$]
Financial Metrics affecting the ALGN estimates:
- Positive: Non-GAAP EPS, $ of 8.60 > 2.29
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 6.82
- Positive: 9.05 < Operating profit margin, % of 16.66
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: Inventory ratio change, % of -1.45 <= -1.03
Short-term ALGN quotes
Long-term ALGN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $3,952.58MM | $3,734.64MM | $3,862.26MM |
| Operating Expenses | $2,976.18MM | $3,092.04MM | $3,218.92MM |
| Operating Income | $976.40MM | $642.60MM | $643.34MM |
| Non-Operating Income | $36.02MM | $-43.54MM | $-2.13MM |
| Interest Expense | $0.00MM | $5.37MM | $0.00MM |
| R&D Expense | $250.31MM | $305.26MM | $346.83MM |
| Income(Loss) | $1,012.42MM | $599.06MM | $641.20MM |
| Taxes | $240.40MM | $237.48MM | $196.15MM |
| Profit(Loss) | $772.02MM | $361.57MM | $445.05MM |
| Stockholders Equity | $3,622.71MM | $3,601.36MM | $3,630.49MM |
| Inventory | $230.23MM | $338.75MM | $296.90MM |
| Assets | $5,942.11MM | $5,947.95MM | $6,083.88MM |
| Operating Cash Flow | $1,172.54MM | $568.73MM | $785.78MM |
| Capital expenditure | $401.10MM | $291.90MM | $177.72MM |
| Investing Cash Flow | $-563.43MM | $-213.32MM | $-195.94MM |
| Financing Cash Flow | $-458.33MM | $-501.69MM | $-598.34MM |
| Earnings Per Share* | $9.78 | $4.62 | $5.82 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.